Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weini'an (nilestriol) versus estradiol valerate for menopause-related symptoms in postmenopausal women
ChiCTR2200066611Phase 4Not yet recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of nilestriol, estradiol valerate and dydrogesterone in menopause (2 arms), sponsored by Peking Union Medical College Hospital. Primary endpoint: Modified Kupperman Index. Planned start Jul 2022; status: not yet recruiting.
02
Drugs
nilestriolestradiol valeratedydrogesterone
03
Conditions
menopause
Beyond the preview
Go deeper on ChiCTR2200066611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200066611.